nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP3A5—prostate cancer	0.081	0.266	CbGaD
Nifedipine—CYP2A6—prostate cancer	0.0784	0.257	CbGaD
Nifedipine—CYP2E1—prostate cancer	0.0557	0.183	CbGaD
Nifedipine—CYP1A1—prostate cancer	0.055	0.18	CbGaD
Nifedipine—CYP3A4—prostate cancer	0.0351	0.115	CbGaD
Nifedipine—ABCC3—Conjugated Estrogens—prostate cancer	0.0218	0.0537	CbGbCtD
Nifedipine—CYP1A1—Flutamide—prostate cancer	0.0175	0.043	CbGbCtD
Nifedipine—ABCC2—Ethinyl Estradiol—prostate cancer	0.0135	0.0332	CbGbCtD
Nifedipine—CYP1A1—Estrone—prostate cancer	0.0126	0.0311	CbGbCtD
Nifedipine—ABCC3—Etoposide—prostate cancer	0.0125	0.0308	CbGbCtD
Nifedipine—CYP2C8—Nilutamide—prostate cancer	0.0122	0.03	CbGbCtD
Nifedipine—CYP3A5—Flutamide—prostate cancer	0.0105	0.0258	CbGbCtD
Nifedipine—CYP2C8—Abiraterone—prostate cancer	0.0101	0.0248	CbGbCtD
Nifedipine—ABCC2—Conjugated Estrogens—prostate cancer	0.0099	0.0244	CbGbCtD
Nifedipine—CYP2E1—Estrone—prostate cancer	0.00976	0.024	CbGbCtD
Nifedipine—CYP2B6—Estrone—prostate cancer	0.00963	0.0237	CbGbCtD
Nifedipine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0094	0.0231	CbGbCtD
Nifedipine—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00858	0.0211	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—prostate cancer	0.00852	0.021	CbGbCtD
Nifedipine—CYP2C9—Nilutamide—prostate cancer	0.00849	0.0209	CbGbCtD
Nifedipine—CYP2C9—Bicalutamide—prostate cancer	0.00849	0.0209	CbGbCtD
Nifedipine—CYP1A2—Flutamide—prostate cancer	0.00781	0.0192	CbGbCtD
Nifedipine—CYP2D6—Bicalutamide—prostate cancer	0.00776	0.0191	CbGbCtD
Nifedipine—CYP3A5—Cabazitaxel—prostate cancer	0.00776	0.0191	CbGbCtD
Nifedipine—ABCB1—Estramustine—prostate cancer	0.00766	0.0189	CbGbCtD
Nifedipine—CYP3A5—Estrone—prostate cancer	0.00758	0.0187	CbGbCtD
Nifedipine—CYP2C8—Cabazitaxel—prostate cancer	0.00746	0.0184	CbGbCtD
Nifedipine—CYP1A1—Estradiol—prostate cancer	0.00726	0.0179	CbGbCtD
Nifedipine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0065	0.016	CbGbCtD
Nifedipine—CYP2D6—Abiraterone—prostate cancer	0.00643	0.0158	CbGbCtD
Nifedipine—CYP3A7—Estradiol—prostate cancer	0.00581	0.0143	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00581	0.0143	CbGbCtD
Nifedipine—CYP2E1—Mitoxantrone—prostate cancer	0.0058	0.0143	CbGbCtD
Nifedipine—ABCC2—Etoposide—prostate cancer	0.00568	0.014	CbGbCtD
Nifedipine—CYP1A2—Estrone—prostate cancer	0.00564	0.0139	CbGbCtD
Nifedipine—ABCC2—Docetaxel—prostate cancer	0.00519	0.0128	CbGbCtD
Nifedipine—CYP2C9—Estrone—prostate cancer	0.00509	0.0125	CbGbCtD
Nifedipine—ABCB1—Cabazitaxel—prostate cancer	0.00505	0.0124	CbGbCtD
Nifedipine—CYP3A4—Bicalutamide—prostate cancer	0.00494	0.0122	CbGbCtD
Nifedipine—ABCB1—Estrone—prostate cancer	0.00494	0.0122	CbGbCtD
Nifedipine—CYP3A4—Estramustine—prostate cancer	0.00459	0.0113	CbGbCtD
Nifedipine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0044	0.0108	CbGbCtD
Nifedipine—CYP3A5—Estradiol—prostate cancer	0.00436	0.0107	CbGbCtD
Nifedipine—CYP2C8—Estradiol—prostate cancer	0.00419	0.0103	CbGbCtD
Nifedipine—CYP3A4—Flutamide—prostate cancer	0.00409	0.0101	CbGbCtD
Nifedipine—CYP3A4—Abiraterone—prostate cancer	0.00409	0.0101	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—prostate cancer	0.00387	0.00954	CbGbCtD
Nifedipine—CYP2C9—Capecitabine—prostate cancer	0.00385	0.00949	CbGbCtD
Nifedipine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00369	0.0091	CbGbCtD
Nifedipine—CYP2E1—Etoposide—prostate cancer	0.00366	0.00902	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00347	0.00855	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—prostate cancer	0.00347	0.00855	CbGbCtD
Nifedipine—CYP1A2—Estradiol—prostate cancer	0.00324	0.00799	CbGbCtD
Nifedipine—ABCB1—Conjugated Estrogens—prostate cancer	0.00323	0.00795	CbGbCtD
Nifedipine—CYP3A4—Cabazitaxel—prostate cancer	0.00303	0.00745	CbGbCtD
Nifedipine—CYP3A4—Estrone—prostate cancer	0.00296	0.00728	CbGbCtD
Nifedipine—ABCB1—Mitoxantrone—prostate cancer	0.00293	0.00723	CbGbCtD
Nifedipine—CYP2C9—Estradiol—prostate cancer	0.00292	0.0072	CbGbCtD
Nifedipine—CYP3A5—Etoposide—prostate cancer	0.00284	0.00701	CbGbCtD
Nifedipine—ABCB1—Estradiol—prostate cancer	0.00283	0.00698	CbGbCtD
Nifedipine—CYP2C8—Etoposide—prostate cancer	0.00273	0.00674	CbGbCtD
Nifedipine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00264	0.00649	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—prostate cancer	0.0026	0.00641	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—prostate cancer	0.00246	0.00607	CbGbCtD
Nifedipine—ABCB1—Prednisone—prostate cancer	0.00244	0.006	CbGbCtD
Nifedipine—CYP1A2—Etoposide—prostate cancer	0.00212	0.00521	CbGbCtD
Nifedipine—CALM2—semen—prostate cancer	0.00206	0.0553	CbGeAlD
Nifedipine—CALM1—semen—prostate cancer	0.00205	0.055	CbGeAlD
Nifedipine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00193	0.00477	CbGbCtD
Nifedipine—ABCB1—Etoposide—prostate cancer	0.00185	0.00456	CbGbCtD
Nifedipine—CYP3A4—Mitoxantrone—prostate cancer	0.00176	0.00433	CbGbCtD
Nifedipine—CYP3A4—Estradiol—prostate cancer	0.0017	0.00418	CbGbCtD
Nifedipine—ABCB1—Docetaxel—prostate cancer	0.00169	0.00417	CbGbCtD
Nifedipine—CYP3A4—Prednisone—prostate cancer	0.00146	0.0036	CbGbCtD
Nifedipine—CACNA1S—seminal vesicle—prostate cancer	0.00137	0.0368	CbGeAlD
Nifedipine—ABCB1—Doxorubicin—prostate cancer	0.00126	0.00311	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—prostate cancer	0.00119	0.00293	CbGbCtD
Nifedipine—CYP1A2—urine—prostate cancer	0.00111	0.0299	CbGeAlD
Nifedipine—CYP3A4—Etoposide—prostate cancer	0.00111	0.00273	CbGbCtD
Nifedipine—CYP2C9—urine—prostate cancer	0.00106	0.0284	CbGeAlD
Nifedipine—CACNA1H—prostate gland—prostate cancer	0.00103	0.0277	CbGeAlD
Nifedipine—CYP3A4—Docetaxel—prostate cancer	0.00101	0.0025	CbGbCtD
Nifedipine—CYP2E1—urine—prostate cancer	0.001	0.0269	CbGeAlD
Nifedipine—CACNB2—prostate gland—prostate cancer	0.000971	0.0261	CbGeAlD
Nifedipine—CACNA2D1—prostate gland—prostate cancer	0.000912	0.0245	CbGeAlD
Nifedipine—CACNA1H—seminal vesicle—prostate cancer	0.00087	0.0234	CbGeAlD
Nifedipine—CACNA1D—prostate gland—prostate cancer	0.000849	0.0228	CbGeAlD
Nifedipine—CYP3A4—urine—prostate cancer	0.000806	0.0217	CbGeAlD
Nifedipine—CYP2D6—urine—prostate cancer	0.000793	0.0213	CbGeAlD
Nifedipine—CACNA1C—prostate gland—prostate cancer	0.000784	0.0211	CbGeAlD
Nifedipine—CYP2A6—prostate gland—prostate cancer	0.000761	0.0205	CbGeAlD
Nifedipine—CYP3A4—Doxorubicin—prostate cancer	0.000756	0.00186	CbGbCtD
Nifedipine—ABCC3—prostate gland—prostate cancer	0.000713	0.0192	CbGeAlD
Nifedipine—CALM3—prostate gland—prostate cancer	0.000656	0.0176	CbGeAlD
Nifedipine—CYP2A6—seminal vesicle—prostate cancer	0.000644	0.0173	CbGeAlD
Nifedipine—ABCC2—prostate gland—prostate cancer	0.00057	0.0153	CbGeAlD
Nifedipine—CALM3—seminal vesicle—prostate cancer	0.000555	0.0149	CbGeAlD
Nifedipine—CALM2—prostate gland—prostate cancer	0.000516	0.0139	CbGeAlD
Nifedipine—CALM1—prostate gland—prostate cancer	0.000513	0.0138	CbGeAlD
Nifedipine—ABCC3—renal system—prostate cancer	0.000486	0.0131	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—prostate cancer	0.00047	0.0126	CbGeAlD
Nifedipine—CACNA1H—testis—prostate cancer	0.000453	0.0122	CbGeAlD
Nifedipine—CALM3—urethra—prostate cancer	0.00044	0.0118	CbGeAlD
Nifedipine—CALM2—seminal vesicle—prostate cancer	0.000436	0.0117	CbGeAlD
Nifedipine—CACNB2—testis—prostate cancer	0.000428	0.0115	CbGeAlD
Nifedipine—CACNA2D1—testis—prostate cancer	0.000402	0.0108	CbGeAlD
Nifedipine—ABCC2—renal system—prostate cancer	0.000388	0.0104	CbGeAlD
Nifedipine—CYP3A5—prostate gland—prostate cancer	0.000386	0.0104	CbGeAlD
Nifedipine—CALM2—epithelium—prostate cancer	0.000379	0.0102	CbGeAlD
Nifedipine—CALM1—epithelium—prostate cancer	0.000377	0.0101	CbGeAlD
Nifedipine—CACNA1D—testis—prostate cancer	0.000374	0.0101	CbGeAlD
Nifedipine—CYP2E1—prostate gland—prostate cancer	0.00036	0.00967	CbGeAlD
Nifedipine—CALM2—renal system—prostate cancer	0.000351	0.00945	CbGeAlD
Nifedipine—CALM1—renal system—prostate cancer	0.00035	0.0094	CbGeAlD
Nifedipine—CACNA1C—testis—prostate cancer	0.000345	0.00928	CbGeAlD
Nifedipine—CALM2—urethra—prostate cancer	0.000345	0.00928	CbGeAlD
Nifedipine—CALM1—urethra—prostate cancer	0.000344	0.00924	CbGeAlD
Nifedipine—CALM3—bone marrow—prostate cancer	0.000338	0.00909	CbGeAlD
Nifedipine—CACNA1H—lymph node—prostate cancer	0.000328	0.00883	CbGeAlD
Nifedipine—Nimodipine—AHR—prostate cancer	0.000319	0.113	CrCbGaD
Nifedipine—ABCC3—testis—prostate cancer	0.000314	0.00844	CbGeAlD
Nifedipine—CACNB2—lymph node—prostate cancer	0.00031	0.00834	CbGeAlD
Nifedipine—CYP2E1—seminal vesicle—prostate cancer	0.000304	0.00818	CbGeAlD
Nifedipine—CACNA2D1—lymph node—prostate cancer	0.000291	0.00783	CbGeAlD
Nifedipine—CYP2C8—renal system—prostate cancer	0.000291	0.00783	CbGeAlD
Nifedipine—CYP1A1—epithelium—prostate cancer	0.00029	0.00779	CbGeAlD
Nifedipine—CALM3—testis—prostate cancer	0.000289	0.00777	CbGeAlD
Nifedipine—CYP1A2—renal system—prostate cancer	0.000273	0.00733	CbGeAlD
Nifedipine—CACNA1D—lymph node—prostate cancer	0.000271	0.00729	CbGeAlD
Nifedipine—CYP1A1—renal system—prostate cancer	0.000269	0.00723	CbGeAlD
Nifedipine—CALM2—bone marrow—prostate cancer	0.000266	0.00714	CbGeAlD
Nifedipine—CALM1—bone marrow—prostate cancer	0.000264	0.00711	CbGeAlD
Nifedipine—CYP1A1—urethra—prostate cancer	0.000264	0.0071	CbGeAlD
Nifedipine—CYP3A5—renal system—prostate cancer	0.000263	0.00707	CbGeAlD
Nifedipine—CYP2B6—renal system—prostate cancer	0.000261	0.00702	CbGeAlD
Nifedipine—ABCC2—testis—prostate cancer	0.000251	0.00675	CbGeAlD
Nifedipine—CACNA1C—lymph node—prostate cancer	0.00025	0.00673	CbGeAlD
Nifedipine—CYP2E1—renal system—prostate cancer	0.000245	0.00659	CbGeAlD
Nifedipine—CYP2E1—urethra—prostate cancer	0.000241	0.00647	CbGeAlD
Nifedipine—ABCC3—lymph node—prostate cancer	0.000228	0.00612	CbGeAlD
Nifedipine—CALM2—testis—prostate cancer	0.000227	0.00611	CbGeAlD
Nifedipine—CALM1—testis—prostate cancer	0.000226	0.00608	CbGeAlD
Nifedipine—CALM3—lymph node—prostate cancer	0.00021	0.00564	CbGeAlD
Nifedipine—ABCB1—prostate gland—prostate cancer	0.000205	0.00551	CbGeAlD
Nifedipine—Lercanidipine—CYP3A5—prostate cancer	0.000198	0.0702	CrCbGaD
Nifedipine—CYP3A4—renal system—prostate cancer	0.000197	0.0053	CbGeAlD
Nifedipine—CYP2D6—renal system—prostate cancer	0.000194	0.00522	CbGeAlD
Nifedipine—CYP2C8—testis—prostate cancer	0.000188	0.00506	CbGeAlD
Nifedipine—ABCC2—lymph node—prostate cancer	0.000182	0.00489	CbGeAlD
Nifedipine—ABCB1—seminal vesicle—prostate cancer	0.000173	0.00466	CbGeAlD
Nifedipine—CYP2B6—testis—prostate cancer	0.000169	0.00454	CbGeAlD
Nifedipine—CALM2—lymph node—prostate cancer	0.000165	0.00443	CbGeAlD
Nifedipine—CALM1—lymph node—prostate cancer	0.000164	0.0044	CbGeAlD
Nifedipine—CYP2E1—testis—prostate cancer	0.000158	0.00426	CbGeAlD
Nifedipine—Nisoldipine—CYP3A5—prostate cancer	0.000151	0.0536	CrCbGaD
Nifedipine—ABCB1—epithelium—prostate cancer	0.000151	0.00405	CbGeAlD
Nifedipine—Nimodipine—CYP3A5—prostate cancer	0.000146	0.0518	CrCbGaD
Nifedipine—Nitrendipine—CYP3A5—prostate cancer	0.000141	0.0501	CrCbGaD
Nifedipine—ABCB1—renal system—prostate cancer	0.00014	0.00375	CbGeAlD
Nifedipine—ABCB1—urethra—prostate cancer	0.000137	0.00369	CbGeAlD
Nifedipine—Nilvadipine—CYP2A6—prostate cancer	0.000137	0.0485	CrCbGaD
Nifedipine—CYP1A1—lymph node—prostate cancer	0.000126	0.00339	CbGeAlD
Nifedipine—CYP2D6—testis—prostate cancer	0.000125	0.00337	CbGeAlD
Nifedipine—Amlodipine—CYP3A5—prostate cancer	0.000122	0.0432	CrCbGaD
Nifedipine—Amlodipine—CYP2A6—prostate cancer	0.000118	0.0418	CrCbGaD
Nifedipine—Felodipine—CYP3A5—prostate cancer	0.000112	0.0399	CrCbGaD
Nifedipine—Clevidipine—CYP2E1—prostate cancer	0.000108	0.0384	CrCbGaD
Nifedipine—Clevidipine—CYP2C19—prostate cancer	0.000107	0.0381	CrCbGaD
Nifedipine—Nicardipine—CYP3A5—prostate cancer	0.000107	0.038	CrCbGaD
Nifedipine—ABCB1—bone marrow—prostate cancer	0.000106	0.00284	CbGeAlD
Nifedipine—Nilvadipine—CYP2E1—prostate cancer	9.71e-05	0.0345	CrCbGaD
Nifedipine—Nilvadipine—CYP2C19—prostate cancer	9.62e-05	0.0341	CrCbGaD
Nifedipine—ABCB1—testis—prostate cancer	9.02e-05	0.00243	CbGeAlD
Nifedipine—Lercanidipine—CYP3A4—prostate cancer	8.56e-05	0.0304	CrCbGaD
Nifedipine—Amlodipine—CYP1A1—prostate cancer	8.25e-05	0.0293	CrCbGaD
Nifedipine—Isradipine—CYP3A4—prostate cancer	7.75e-05	0.0275	CrCbGaD
Nifedipine—Nicardipine—CYP2E1—prostate cancer	7.36e-05	0.0261	CrCbGaD
Nifedipine—Nicardipine—CYP2C19—prostate cancer	7.29e-05	0.0259	CrCbGaD
Nifedipine—Clevidipine—CYP3A4—prostate cancer	6.82e-05	0.0242	CrCbGaD
Nifedipine—ABCB1—lymph node—prostate cancer	6.54e-05	0.00176	CbGeAlD
Nifedipine—Nisoldipine—CYP3A4—prostate cancer	6.54e-05	0.0232	CrCbGaD
Nifedipine—Nimodipine—CYP3A4—prostate cancer	6.31e-05	0.0224	CrCbGaD
Nifedipine—Nilvadipine—CYP3A4—prostate cancer	6.11e-05	0.0217	CrCbGaD
Nifedipine—Nitrendipine—CYP3A4—prostate cancer	6.11e-05	0.0217	CrCbGaD
Nifedipine—Amlodipine—CYP3A4—prostate cancer	5.26e-05	0.0187	CrCbGaD
Nifedipine—Felodipine—CYP3A4—prostate cancer	4.87e-05	0.0173	CrCbGaD
Nifedipine—Nicardipine—CYP3A4—prostate cancer	4.63e-05	0.0164	CrCbGaD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.24e-05	0.000163	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—prostate cancer	2.24e-05	0.000162	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—prostate cancer	2.23e-05	0.000162	CcSEcCtD
Nifedipine—Discomfort—Prednisone—prostate cancer	2.23e-05	0.000162	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—prostate cancer	2.22e-05	0.000162	CcSEcCtD
Nifedipine—Hypersensitivity—Etoposide—prostate cancer	2.22e-05	0.000162	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—prostate cancer	2.22e-05	0.000161	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—prostate cancer	2.21e-05	0.000161	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.21e-05	0.000161	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—prostate cancer	2.21e-05	0.000161	CcSEcCtD
Nifedipine—Flushing—Epirubicin—prostate cancer	2.21e-05	0.000161	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—prostate cancer	2.21e-05	0.00016	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—prostate cancer	2.21e-05	0.00016	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—prostate cancer	2.2e-05	0.00016	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—prostate cancer	2.2e-05	0.00016	CcSEcCtD
Nifedipine—Insomnia—Capecitabine—prostate cancer	2.2e-05	0.00016	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—prostate cancer	2.19e-05	0.000159	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—prostate cancer	2.19e-05	0.000159	CcSEcCtD
Nifedipine—Paraesthesia—Capecitabine—prostate cancer	2.18e-05	0.000158	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—prostate cancer	2.18e-05	0.000158	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—prostate cancer	2.18e-05	0.000158	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—prostate cancer	2.17e-05	0.000158	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Asthenia—Etoposide—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Dyspnoea—Capecitabine—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Oedema—Prednisone—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Anaphylactic shock—Prednisone—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—prostate cancer	2.16e-05	0.000157	CcSEcCtD
Nifedipine—Nausea—Mitoxantrone—prostate cancer	2.15e-05	0.000157	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—prostate cancer	2.15e-05	0.000156	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—prostate cancer	2.15e-05	0.000156	CcSEcCtD
Nifedipine—Pain—Docetaxel—prostate cancer	2.14e-05	0.000156	CcSEcCtD
Nifedipine—Constipation—Docetaxel—prostate cancer	2.14e-05	0.000156	CcSEcCtD
Nifedipine—Dyspepsia—Capecitabine—prostate cancer	2.14e-05	0.000155	CcSEcCtD
Nifedipine—Chills—Epirubicin—prostate cancer	2.14e-05	0.000155	CcSEcCtD
Nifedipine—Pruritus—Etoposide—prostate cancer	2.13e-05	0.000155	CcSEcCtD
Nifedipine—Shock—Prednisone—prostate cancer	2.13e-05	0.000155	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—prostate cancer	2.13e-05	0.000155	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—prostate cancer	2.12e-05	0.000154	CcSEcCtD
Nifedipine—Nervous system disorder—Prednisone—prostate cancer	2.12e-05	0.000154	CcSEcCtD
Nifedipine—Tachycardia—Prednisone—prostate cancer	2.11e-05	0.000153	CcSEcCtD
Nifedipine—Decreased appetite—Capecitabine—prostate cancer	2.11e-05	0.000153	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—prostate cancer	2.1e-05	0.000153	CcSEcCtD
Nifedipine—Skin disorder—Prednisone—prostate cancer	2.1e-05	0.000153	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.1e-05	0.000152	CcSEcCtD
Nifedipine—Fatigue—Capecitabine—prostate cancer	2.09e-05	0.000152	CcSEcCtD
Nifedipine—Hyperhidrosis—Prednisone—prostate cancer	2.09e-05	0.000152	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—prostate cancer	2.09e-05	0.000152	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—prostate cancer	2.08e-05	0.000151	CcSEcCtD
Nifedipine—Constipation—Capecitabine—prostate cancer	2.08e-05	0.000151	CcSEcCtD
Nifedipine—Pain—Capecitabine—prostate cancer	2.08e-05	0.000151	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—prostate cancer	2.07e-05	0.000151	CcSEcCtD
Nifedipine—Erythema—Epirubicin—prostate cancer	2.07e-05	0.000151	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—prostate cancer	2.07e-05	0.00015	CcSEcCtD
Nifedipine—Diarrhoea—Etoposide—prostate cancer	2.06e-05	0.00015	CcSEcCtD
Nifedipine—Anorexia—Prednisone—prostate cancer	2.06e-05	0.00015	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—prostate cancer	2.06e-05	0.00015	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—prostate cancer	2.05e-05	0.000149	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—prostate cancer	2.05e-05	0.000149	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—prostate cancer	2.04e-05	0.000149	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—prostate cancer	2.04e-05	0.000149	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—prostate cancer	2.04e-05	0.000148	CcSEcCtD
Nifedipine—Tension—Epirubicin—prostate cancer	2.03e-05	0.000148	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—prostate cancer	2.03e-05	0.000147	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—prostate cancer	2.01e-05	0.000146	CcSEcCtD
Nifedipine—Back pain—Epirubicin—prostate cancer	2e-05	0.000146	CcSEcCtD
Nifedipine—Feeling abnormal—Capecitabine—prostate cancer	2e-05	0.000145	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—prostate cancer	2e-05	0.000145	CcSEcCtD
Nifedipine—Dizziness—Etoposide—prostate cancer	2e-05	0.000145	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—prostate cancer	1.99e-05	0.000145	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—prostate cancer	1.99e-05	0.000145	CcSEcCtD
Nifedipine—Gastrointestinal pain—Capecitabine—prostate cancer	1.99e-05	0.000144	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—prostate cancer	1.99e-05	0.000144	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—prostate cancer	1.98e-05	0.000144	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—prostate cancer	1.98e-05	0.000144	CcSEcCtD
Nifedipine—Chills—Doxorubicin—prostate cancer	1.98e-05	0.000144	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Prednisone—prostate cancer	1.97e-05	0.000143	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—prostate cancer	1.97e-05	0.000143	CcSEcCtD
Nifedipine—Insomnia—Prednisone—prostate cancer	1.96e-05	0.000142	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—prostate cancer	1.95e-05	0.000142	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—prostate cancer	1.95e-05	0.000141	CcSEcCtD
Nifedipine—Paraesthesia—Prednisone—prostate cancer	1.94e-05	0.000141	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—prostate cancer	1.93e-05	0.00014	CcSEcCtD
Nifedipine—Urticaria—Capecitabine—prostate cancer	1.93e-05	0.00014	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—prostate cancer	1.92e-05	0.00014	CcSEcCtD
Nifedipine—Body temperature increased—Capecitabine—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Abdominal pain—Capecitabine—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Vomiting—Etoposide—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—prostate cancer	1.92e-05	0.000139	CcSEcCtD
Nifedipine—Agitation—Epirubicin—prostate cancer	1.9e-05	0.000138	CcSEcCtD
Nifedipine—Dyspepsia—Prednisone—prostate cancer	1.9e-05	0.000138	CcSEcCtD
Nifedipine—Rash—Etoposide—prostate cancer	1.9e-05	0.000138	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—prostate cancer	1.9e-05	0.000138	CcSEcCtD
Nifedipine—Headache—Etoposide—prostate cancer	1.89e-05	0.000137	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—prostate cancer	1.89e-05	0.000137	CcSEcCtD
Nifedipine—Tension—Doxorubicin—prostate cancer	1.88e-05	0.000137	CcSEcCtD
Nifedipine—Decreased appetite—Prednisone—prostate cancer	1.88e-05	0.000137	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—prostate cancer	1.88e-05	0.000136	CcSEcCtD
Nifedipine—Malaise—Epirubicin—prostate cancer	1.87e-05	0.000136	CcSEcCtD
Nifedipine—Fatigue—Prednisone—prostate cancer	1.86e-05	0.000135	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—prostate cancer	1.86e-05	0.000135	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—prostate cancer	1.86e-05	0.000135	CcSEcCtD
Nifedipine—Syncope—Epirubicin—prostate cancer	1.86e-05	0.000135	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—prostate cancer	1.86e-05	0.000135	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—prostate cancer	1.85e-05	0.000135	CcSEcCtD
Nifedipine—Constipation—Prednisone—prostate cancer	1.85e-05	0.000134	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—prostate cancer	1.85e-05	0.000134	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—prostate cancer	1.84e-05	0.000134	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—prostate cancer	1.83e-05	0.000133	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—prostate cancer	1.82e-05	0.000132	CcSEcCtD
Nifedipine—Cough—Epirubicin—prostate cancer	1.81e-05	0.000131	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—prostate cancer	1.81e-05	0.000131	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—prostate cancer	1.8e-05	0.000131	CcSEcCtD
Nifedipine—Nausea—Etoposide—prostate cancer	1.79e-05	0.00013	CcSEcCtD
Nifedipine—Hypersensitivity—Capecitabine—prostate cancer	1.79e-05	0.00013	CcSEcCtD
Nifedipine—Feeling abnormal—Prednisone—prostate cancer	1.78e-05	0.00013	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—prostate cancer	1.78e-05	0.000129	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—prostate cancer	1.77e-05	0.000129	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—prostate cancer	1.77e-05	0.000129	CcSEcCtD
Nifedipine—Gastrointestinal pain—Prednisone—prostate cancer	1.77e-05	0.000129	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—prostate cancer	1.76e-05	0.000128	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—prostate cancer	1.76e-05	0.000128	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—prostate cancer	1.76e-05	0.000128	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—prostate cancer	1.76e-05	0.000128	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—prostate cancer	1.76e-05	0.000128	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.75e-05	0.000127	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—prostate cancer	1.74e-05	0.000127	CcSEcCtD
Nifedipine—Asthenia—Capecitabine—prostate cancer	1.74e-05	0.000127	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—prostate cancer	1.73e-05	0.000126	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—prostate cancer	1.73e-05	0.000125	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Urticaria—Prednisone—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Pruritus—Capecitabine—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—prostate cancer	1.72e-05	0.000125	CcSEcCtD
Nifedipine—Body temperature increased—Prednisone—prostate cancer	1.71e-05	0.000124	CcSEcCtD
Nifedipine—Abdominal pain—Prednisone—prostate cancer	1.71e-05	0.000124	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—prostate cancer	1.71e-05	0.000124	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—prostate cancer	1.69e-05	0.000123	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—prostate cancer	1.69e-05	0.000123	CcSEcCtD
Nifedipine—Oedema—Epirubicin—prostate cancer	1.69e-05	0.000123	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—prostate cancer	1.69e-05	0.000122	CcSEcCtD
Nifedipine—Cough—Doxorubicin—prostate cancer	1.67e-05	0.000122	CcSEcCtD
Nifedipine—Shock—Epirubicin—prostate cancer	1.66e-05	0.000121	CcSEcCtD
Nifedipine—Diarrhoea—Capecitabine—prostate cancer	1.66e-05	0.000121	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—prostate cancer	1.66e-05	0.000121	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—prostate cancer	1.66e-05	0.000121	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—prostate cancer	1.66e-05	0.00012	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—prostate cancer	1.65e-05	0.00012	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—prostate cancer	1.64e-05	0.000119	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—prostate cancer	1.64e-05	0.000119	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—prostate cancer	1.63e-05	0.000119	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—prostate cancer	1.63e-05	0.000119	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—prostate cancer	1.63e-05	0.000119	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—prostate cancer	1.63e-05	0.000118	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.62e-05	0.000118	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—prostate cancer	1.61e-05	0.000117	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—prostate cancer	1.61e-05	0.000117	CcSEcCtD
Nifedipine—Dizziness—Capecitabine—prostate cancer	1.61e-05	0.000117	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—prostate cancer	1.6e-05	0.000116	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—prostate cancer	1.59e-05	0.000116	CcSEcCtD
Nifedipine—Hypersensitivity—Prednisone—prostate cancer	1.59e-05	0.000116	CcSEcCtD
Nifedipine—Rash—Docetaxel—prostate cancer	1.58e-05	0.000115	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—prostate cancer	1.58e-05	0.000115	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—prostate cancer	1.58e-05	0.000115	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—prostate cancer	1.58e-05	0.000115	CcSEcCtD
Nifedipine—Headache—Docetaxel—prostate cancer	1.57e-05	0.000114	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—prostate cancer	1.57e-05	0.000114	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—prostate cancer	1.57e-05	0.000114	CcSEcCtD
Nifedipine—Asthenia—Prednisone—prostate cancer	1.55e-05	0.000113	CcSEcCtD
Nifedipine—Vomiting—Capecitabine—prostate cancer	1.54e-05	0.000112	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.54e-05	0.000112	CcSEcCtD
Nifedipine—Shock—Doxorubicin—prostate cancer	1.54e-05	0.000112	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—prostate cancer	1.53e-05	0.000112	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Rash—Capecitabine—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Pruritus—Prednisone—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Dermatitis—Capecitabine—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—prostate cancer	1.53e-05	0.000111	CcSEcCtD
Nifedipine—Headache—Capecitabine—prostate cancer	1.52e-05	0.000111	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—prostate cancer	1.52e-05	0.00011	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—prostate cancer	1.52e-05	0.00011	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—prostate cancer	1.51e-05	0.00011	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—prostate cancer	1.51e-05	0.00011	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—prostate cancer	1.5e-05	0.000109	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—prostate cancer	1.49e-05	0.000108	CcSEcCtD
Nifedipine—Nausea—Docetaxel—prostate cancer	1.49e-05	0.000108	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—prostate cancer	1.49e-05	0.000108	CcSEcCtD
Nifedipine—Diarrhoea—Prednisone—prostate cancer	1.48e-05	0.000108	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—prostate cancer	1.47e-05	0.000107	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—prostate cancer	1.46e-05	0.000106	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.46e-05	0.000106	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—prostate cancer	1.46e-05	0.000106	CcSEcCtD
Nifedipine—Pain—Epirubicin—prostate cancer	1.45e-05	0.000105	CcSEcCtD
Nifedipine—Constipation—Epirubicin—prostate cancer	1.45e-05	0.000105	CcSEcCtD
Nifedipine—Nausea—Capecitabine—prostate cancer	1.44e-05	0.000105	CcSEcCtD
Nifedipine—Dizziness—Prednisone—prostate cancer	1.43e-05	0.000104	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.43e-05	0.000104	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—prostate cancer	1.42e-05	0.000103	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—prostate cancer	1.41e-05	0.000102	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—prostate cancer	1.4e-05	0.000101	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—prostate cancer	1.39e-05	0.000101	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—prostate cancer	1.39e-05	0.000101	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—prostate cancer	1.38e-05	0.000101	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—prostate cancer	1.38e-05	0.0001	CcSEcCtD
Nifedipine—Vomiting—Prednisone—prostate cancer	1.38e-05	9.99e-05	CcSEcCtD
Nifedipine—Rash—Prednisone—prostate cancer	1.36e-05	9.91e-05	CcSEcCtD
Nifedipine—Dermatitis—Prednisone—prostate cancer	1.36e-05	9.9e-05	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—prostate cancer	1.36e-05	9.89e-05	CcSEcCtD
Nifedipine—Headache—Prednisone—prostate cancer	1.35e-05	9.85e-05	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.35e-05	9.82e-05	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—prostate cancer	1.35e-05	9.81e-05	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—prostate cancer	1.34e-05	9.76e-05	CcSEcCtD
Nifedipine—Pain—Doxorubicin—prostate cancer	1.34e-05	9.73e-05	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—prostate cancer	1.34e-05	9.73e-05	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—prostate cancer	1.34e-05	9.72e-05	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—prostate cancer	1.34e-05	9.72e-05	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—prostate cancer	1.29e-05	9.37e-05	CcSEcCtD
Nifedipine—Nausea—Prednisone—prostate cancer	1.28e-05	9.33e-05	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.28e-05	9.3e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—prostate cancer	1.25e-05	9.06e-05	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—prostate cancer	1.24e-05	9.03e-05	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—prostate cancer	1.24e-05	8.99e-05	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—prostate cancer	1.24e-05	8.99e-05	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—prostate cancer	1.21e-05	8.82e-05	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—prostate cancer	1.2e-05	8.7e-05	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—prostate cancer	1.16e-05	8.41e-05	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—prostate cancer	1.15e-05	8.38e-05	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—prostate cancer	1.12e-05	8.16e-05	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—prostate cancer	1.12e-05	8.13e-05	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—prostate cancer	1.11e-05	8.05e-05	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—prostate cancer	1.08e-05	7.81e-05	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—prostate cancer	1.07e-05	7.78e-05	CcSEcCtD
Nifedipine—Rash—Epirubicin—prostate cancer	1.07e-05	7.75e-05	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—prostate cancer	1.07e-05	7.74e-05	CcSEcCtD
Nifedipine—Headache—Epirubicin—prostate cancer	1.06e-05	7.7e-05	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—prostate cancer	1.03e-05	7.52e-05	CcSEcCtD
Nifedipine—Nausea—Epirubicin—prostate cancer	1e-05	7.3e-05	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—prostate cancer	9.95e-06	7.23e-05	CcSEcCtD
Nifedipine—Rash—Doxorubicin—prostate cancer	9.87e-06	7.17e-05	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—prostate cancer	9.86e-06	7.16e-05	CcSEcCtD
Nifedipine—Headache—Doxorubicin—prostate cancer	9.8e-06	7.12e-05	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—prostate cancer	9.3e-06	6.76e-05	CcSEcCtD
Nifedipine—CYP2C8—Metabolism—NOS3—prostate cancer	6.12e-07	5.5e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—prostate cancer	6.11e-07	5.49e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MTHFR—prostate cancer	6.1e-07	5.49e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—prostate cancer	6.1e-07	5.48e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—INS—prostate cancer	6.08e-07	5.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAP2K1—prostate cancer	6.07e-07	5.45e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAP2K1—prostate cancer	6.07e-07	5.45e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—prostate cancer	6.05e-07	5.44e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—RXRA—prostate cancer	6.05e-07	5.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—prostate cancer	6.03e-07	5.42e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—prostate cancer	6.03e-07	5.42e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—SRC—prostate cancer	6.01e-07	5.4e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—SRC—prostate cancer	6.01e-07	5.4e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—prostate cancer	6e-07	5.39e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—prostate cancer	5.99e-07	5.39e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PPARA—prostate cancer	5.99e-07	5.38e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FGF2—prostate cancer	5.97e-07	5.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SERPINE1—prostate cancer	5.96e-07	5.36e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SERPINE1—prostate cancer	5.96e-07	5.36e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CREBBP—prostate cancer	5.96e-07	5.35e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—prostate cancer	5.9e-07	5.3e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—prostate cancer	5.9e-07	5.3e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—prostate cancer	5.9e-07	5.3e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NOS3—prostate cancer	5.88e-07	5.29e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—COMT—prostate cancer	5.83e-07	5.24e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—prostate cancer	5.8e-07	5.21e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—prostate cancer	5.8e-07	5.21e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—prostate cancer	5.8e-07	5.21e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FGF2—prostate cancer	5.77e-07	5.19e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FGF2—prostate cancer	5.77e-07	5.19e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—prostate cancer	5.77e-07	5.18e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—INS—prostate cancer	5.73e-07	5.15e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JAK2—prostate cancer	5.72e-07	5.14e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—prostate cancer	5.71e-07	5.13e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—prostate cancer	5.71e-07	5.13e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ITPR1—prostate cancer	5.71e-07	5.13e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NOS3—prostate cancer	5.69e-07	5.12e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NOS3—prostate cancer	5.69e-07	5.12e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—INS—prostate cancer	5.68e-07	5.11e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—prostate cancer	5.65e-07	5.08e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—prostate cancer	5.65e-07	5.08e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—prostate cancer	5.65e-07	5.08e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—prostate cancer	5.64e-07	5.07e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAV1—prostate cancer	5.63e-07	5.06e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CREBBP—prostate cancer	5.61e-07	5.04e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—prostate cancer	5.61e-07	5.04e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—prostate cancer	5.6e-07	5.04e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—prostate cancer	5.6e-07	5.03e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—prostate cancer	5.58e-07	5.02e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—prostate cancer	5.57e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—prostate cancer	5.57e-07	5.01e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CREBBP—prostate cancer	5.56e-07	5e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—TGFB1—prostate cancer	5.56e-07	4.99e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JAK2—prostate cancer	5.53e-07	4.97e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JAK2—prostate cancer	5.53e-07	4.97e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—prostate cancer	5.5e-07	4.95e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—prostate cancer	5.5e-07	4.94e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—EP300—prostate cancer	5.5e-07	4.94e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—prostate cancer	5.45e-07	4.9e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—prostate cancer	5.43e-07	4.88e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—prostate cancer	5.43e-07	4.88e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—prostate cancer	5.43e-07	4.88e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	5.42e-07	4.87e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	5.42e-07	4.87e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—prostate cancer	5.4e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—prostate cancer	5.4e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—prostate cancer	5.39e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—prostate cancer	5.39e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—prostate cancer	5.39e-07	4.85e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—prostate cancer	5.39e-07	4.84e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—prostate cancer	5.39e-07	4.84e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—EP300—prostate cancer	5.39e-07	4.84e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.38e-07	4.83e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—EP300—prostate cancer	5.38e-07	4.83e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—TGFB1—prostate cancer	5.37e-07	4.83e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—TGFB1—prostate cancer	5.37e-07	4.83e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—EP300—prostate cancer	5.35e-07	4.81e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—NOS3—prostate cancer	5.33e-07	4.79e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—prostate cancer	5.33e-07	4.79e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—prostate cancer	5.33e-07	4.79e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—prostate cancer	5.32e-07	4.78e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—prostate cancer	5.32e-07	4.78e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.32e-07	4.78e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.28e-07	4.74e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—prostate cancer	5.27e-07	4.74e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—prostate cancer	5.27e-07	4.74e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—prostate cancer	5.25e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—prostate cancer	5.25e-07	4.72e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—LPL—prostate cancer	5.23e-07	4.7e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—prostate cancer	5.22e-07	4.69e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—EP300—prostate cancer	5.18e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—EP300—prostate cancer	5.18e-07	4.65e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—prostate cancer	5.15e-07	4.62e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—prostate cancer	5.13e-07	4.61e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—prostate cancer	5.12e-07	4.6e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—prostate cancer	5.1e-07	4.58e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—EP300—prostate cancer	5.08e-07	4.56e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.05e-07	4.54e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—prostate cancer	5.05e-07	4.54e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—prostate cancer	5.05e-07	4.54e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—prostate cancer	5.04e-07	4.53e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—NOS3—prostate cancer	5.03e-07	4.52e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ERCC2—prostate cancer	5.01e-07	4.5e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—prostate cancer	5e-07	4.49e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—prostate cancer	4.99e-07	4.48e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—NOS3—prostate cancer	4.98e-07	4.48e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—prostate cancer	4.98e-07	4.47e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—prostate cancer	4.98e-07	4.47e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—prostate cancer	4.96e-07	4.46e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—prostate cancer	4.95e-07	4.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—prostate cancer	4.95e-07	4.45e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—prostate cancer	4.93e-07	4.43e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—prostate cancer	4.93e-07	4.43e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—prostate cancer	4.92e-07	4.42e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—prostate cancer	4.88e-07	4.39e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—prostate cancer	4.88e-07	4.38e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—prostate cancer	4.86e-07	4.37e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—INS—prostate cancer	4.85e-07	4.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—prostate cancer	4.83e-07	4.34e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—prostate cancer	4.83e-07	4.34e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—prostate cancer	4.82e-07	4.34e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—prostate cancer	4.82e-07	4.34e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—prostate cancer	4.81e-07	4.33e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—prostate cancer	4.8e-07	4.31e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—prostate cancer	4.8e-07	4.31e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CREBBP—prostate cancer	4.75e-07	4.27e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—prostate cancer	4.73e-07	4.25e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—prostate cancer	4.72e-07	4.24e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MTHFR—prostate cancer	4.71e-07	4.23e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1A—prostate cancer	4.7e-07	4.23e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—prostate cancer	4.7e-07	4.23e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—prostate cancer	4.7e-07	4.23e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—prostate cancer	4.69e-07	4.22e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—prostate cancer	4.66e-07	4.19e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—prostate cancer	4.66e-07	4.19e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—EP300—prostate cancer	4.66e-07	4.18e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—prostate cancer	4.64e-07	4.17e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPARA—prostate cancer	4.62e-07	4.15e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.6e-07	4.13e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—prostate cancer	4.6e-07	4.13e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—prostate cancer	4.58e-07	4.11e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—prostate cancer	4.57e-07	4.11e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—prostate cancer	4.57e-07	4.11e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—prostate cancer	4.57e-07	4.1e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—prostate cancer	4.57e-07	4.1e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—prostate cancer	4.56e-07	4.09e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1A—prostate cancer	4.55e-07	4.09e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1A—prostate cancer	4.55e-07	4.09e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—prostate cancer	4.54e-07	4.08e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—prostate cancer	4.54e-07	4.08e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—prostate cancer	4.53e-07	4.08e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—prostate cancer	4.51e-07	4.05e-06	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—prostate cancer	4.49e-07	4.04e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EP300—prostate cancer	4.48e-07	4.02e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—prostate cancer	4.43e-07	3.98e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—prostate cancer	4.43e-07	3.98e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—prostate cancer	4.39e-07	3.94e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—prostate cancer	4.39e-07	3.94e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—SRC—prostate cancer	4.35e-07	3.91e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAV1—prostate cancer	4.34e-07	3.9e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EP300—prostate cancer	4.33e-07	3.89e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EP300—prostate cancer	4.33e-07	3.89e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—NOS3—prostate cancer	4.26e-07	3.83e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—prostate cancer	4.25e-07	3.82e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—prostate cancer	4.24e-07	3.81e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—SRC—prostate cancer	4.21e-07	3.78e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—SRC—prostate cancer	4.21e-07	3.78e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—prostate cancer	4.2e-07	3.77e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—prostate cancer	4.19e-07	3.76e-06	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—prostate cancer	4.18e-07	3.76e-06	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—prostate cancer	4.12e-07	3.7e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—prostate cancer	4.1e-07	3.69e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—prostate cancer	4.1e-07	3.69e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.07e-07	3.66e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—prostate cancer	4.06e-07	3.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—prostate cancer	4.06e-07	3.65e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—EP300—prostate cancer	4.06e-07	3.65e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—prostate cancer	4.05e-07	3.64e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—prostate cancer	4.05e-07	3.64e-06	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—prostate cancer	4.05e-07	3.64e-06	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—prostate cancer	4.05e-07	3.64e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—prostate cancer	4.01e-07	3.6e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—prostate cancer	3.98e-07	3.58e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—prostate cancer	3.98e-07	3.57e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—prostate cancer	3.97e-07	3.57e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—prostate cancer	3.96e-07	3.56e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.96e-07	3.56e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—prostate cancer	3.93e-07	3.53e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—prostate cancer	3.9e-07	3.51e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—prostate cancer	3.89e-07	3.5e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TGFB1—prostate cancer	3.89e-07	3.5e-06	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—prostate cancer	3.86e-07	3.47e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—prostate cancer	3.83e-07	3.44e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—prostate cancer	3.83e-07	3.44e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—EP300—prostate cancer	3.82e-07	3.44e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—prostate cancer	3.81e-07	3.43e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—EP300—prostate cancer	3.79e-07	3.41e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—prostate cancer	3.77e-07	3.39e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—prostate cancer	3.77e-07	3.39e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TGFB1—prostate cancer	3.76e-07	3.38e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TGFB1—prostate cancer	3.76e-07	3.38e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—prostate cancer	3.76e-07	3.38e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—INS—prostate cancer	3.75e-07	3.37e-06	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—prostate cancer	3.74e-07	3.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—prostate cancer	3.74e-07	3.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—prostate cancer	3.69e-07	3.32e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—prostate cancer	3.69e-07	3.32e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.67e-07	3.3e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—prostate cancer	3.6e-07	3.24e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—prostate cancer	3.49e-07	3.13e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—prostate cancer	3.49e-07	3.13e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.48e-07	3.13e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.44e-07	3.1e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—prostate cancer	3.4e-07	3.05e-06	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—prostate cancer	3.32e-07	2.99e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—prostate cancer	3.31e-07	2.98e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—NOS3—prostate cancer	3.29e-07	2.95e-06	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—prostate cancer	3.26e-07	2.93e-06	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—prostate cancer	3.25e-07	2.92e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—EP300—prostate cancer	3.24e-07	2.91e-06	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—prostate cancer	3.23e-07	2.91e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—prostate cancer	3.2e-07	2.88e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—prostate cancer	3.2e-07	2.88e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—prostate cancer	3.2e-07	2.88e-06	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—prostate cancer	3.13e-07	2.81e-06	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—prostate cancer	3.13e-07	2.81e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—prostate cancer	3.1e-07	2.78e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—prostate cancer	3.1e-07	2.78e-06	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—prostate cancer	3.07e-07	2.76e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.03e-07	2.73e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—prostate cancer	3e-07	2.7e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—prostate cancer	3e-07	2.7e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—prostate cancer	2.93e-07	2.63e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—prostate cancer	2.84e-07	2.55e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—prostate cancer	2.84e-07	2.55e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.83e-07	2.54e-06	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—prostate cancer	2.81e-07	2.53e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—prostate cancer	2.8e-07	2.52e-06	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—prostate cancer	2.7e-07	2.43e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—prostate cancer	2.62e-07	2.36e-06	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—prostate cancer	2.62e-07	2.35e-06	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—prostate cancer	2.62e-07	2.35e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—EP300—prostate cancer	2.5e-07	2.25e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—prostate cancer	2.45e-07	2.2e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.4e-07	2.15e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—prostate cancer	2.31e-07	2.08e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—prostate cancer	2.29e-07	2.06e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—prostate cancer	1.96e-07	1.76e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.85e-07	1.66e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—prostate cancer	1.51e-07	1.36e-06	CbGpPWpGaD
